Triasima Portfolio Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,425
Closed -$428K 144
2022
Q4
$428K Sell
2,425
-4,000
-62% -$691K 0.03% 106
2022
Q3
$1.05M Hold
6,425
0.09% 95
2022
Q2
$1.14M Buy
6,425
+2,425
+61% +$432K 0.08% 92
2022
Q1
$709K Hold
4,000
0.03% 117
2021
Q4
$684K Hold
4,000
0.03% 118
2021
Q3
$646K Hold
4,000
0.03% 118
2021
Q2
$659K Hold
4,000
0.03% 132
2021
Q1
$657K Hold
4,000
0.03% 135
2020
Q4
$630K Buy
+4,000
New +$590K 0.04% 125

Other funds holding JNJ

Triasima Portfolio Management's JNJ Position: Q1 2023 in Review

Triasima Portfolio Management sold out of Johnson & Johnson (JNJ) in Q1 2023, closing a stake of 2,425 shares — an estimated $428K sold.

Triasima Portfolio Management first reported a position in JNJ in Q4 2020 and held it in 9 quarters. The position peaked at $1.14M in Q2 2022. 3,729 funds tracked by Wall St. Rank hold JNJ as of Q1 2023.

  • Triasima Portfolio Management reported no remaining Johnson & Johnson position as of Q1 2023 after selling out during the quarter.
  • Triasima Portfolio Management sold 2,425 Johnson & Johnson shares in Q1 2023, an estimated $428K.
  • Triasima Portfolio Management first reported a position in Johnson & Johnson in Q4 2020 and held it in 9 quarters.
  • Triasima Portfolio Management's Johnson & Johnson position peaked at $1.14M in Q2 2022.
  • 3,729 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2023.

Based on Triasima Portfolio Management's 13F filing for Q1 2023, filed 28 Apr 2023.